Literature DB >> 22823248

Impact of polymorphic variation at 7p15.3, 3p22.1 and 2p23.3 loci on risk of multiple myeloma.

Alessandro Martino, Daniele Campa, Krzysztof Jamroziak, Rui Manuel Reis, Juan Sainz, Gabriele Buda, Ramón García-Sanz, Fabienne Lesueur, Herlander Marques, Victor Moreno, Manuel Jurado, Rafael Ríos, Zofia Szemraj-Rogucka, Janusz Szemraj, Anne Tjønneland, Kim Overvad, Annette Juul Vangsted, Ulla Vogel, Gabor Mikala, Katalin Kádár, Gergely Szombath, Judit Varkonyi, Enrico Orciuolo, Charles Dumontet, Federica Gemignani, Anna Maria Rossi, Stefano Landi, Mario Petrini, Richard S Houlston, Kari Hemminki, Federico Canzian.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22823248     DOI： 10.1111/j.1365-2141.2012.09244.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  8 in total

1.  A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci.

Authors:  Kristin A Rand; Chi Song; Eric Dean; Daniel J Serie; Karen Curtin; Xin Sheng; Donglei Hu; Carol Ann Huff; Leon Bernal-Mizrachi; Michael H Tomasson; Sikander Ailawadhi; Seema Singhal; Karen Pawlish; Edward S Peters; Cathryn H Bock; Alex Stram; David J Van Den Berg; Christopher K Edlund; David V Conti; Todd Zimmerman; Amie E Hwang; Scott Huntsman; John Graff; Ajay Nooka; Yinfei Kong; Silvana L Pregja; Sonja I Berndt; William J Blot; John Carpten; Graham Casey; Lisa Chu; W Ryan Diver; Victoria L Stevens; Michael R Lieber; Phyllis J Goodman; Anselm J M Hennis; Ann W Hsing; Jayesh Mehta; Rick A Kittles; Suzanne Kolb; Eric A Klein; Cristina Leske; Adam B Murphy; Barbara Nemesure; Christine Neslund-Dudas; Sara S Strom; Ravi Vij; Benjamin A Rybicki; Janet L Stanford; Lisa B Signorello; John S Witte; Christine B Ambrosone; Parveen Bhatti; Esther M John; Leslie Bernstein; Wei Zheng; Andrew F Olshan; Jennifer J Hu; Regina G Ziegler; Sarah J Nyante; Elisa V Bandera; Brenda M Birmann; Sue A Ingles; Michael F Press; Djordje Atanackovic; Martha J Glenn; Lisa A Cannon-Albright; Brandt Jones; Guido Tricot; Thomas G Martin; Shaji K Kumar; Jeffrey L Wolf; Sandra L Deming Halverson; Nathaniel Rothman; Angela R Brooks-Wilson; S Vincent Rajkumar; Laurence N Kolonel; Stephen J Chanock; Susan L Slager; Richard K Severson; Nalini Janakiraman; Howard R Terebelo; Elizabeth E Brown; Anneclaire J De Roos; Ann F Mohrbacher; Graham A Colditz; Graham G Giles; John J Spinelli; Brian C Chiu; Nikhil C Munshi; Kenneth C Anderson; Joan Levy; Jeffrey A Zonder; Robert Z Orlowski; Sagar Lonial; Nicola J Camp; Celine M Vachon; Elad Ziv; Daniel O Stram; Dennis J Hazelett; Christopher A Haiman; Wendy Cozen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-09-01       Impact factor: 4.254

2.  Inherited predisposition to multiple myeloma.

Authors:  Divya T Koura; Amelia A Langston
Journal:  Ther Adv Hematol       Date:  2013-08

Review 3.  Biologic frontiers in multiple myeloma: from biomarker identification to clinical practice.

Authors:  Ola Landgren; Gareth J Morgan
Journal:  Clin Cancer Res       Date:  2013-11-22       Impact factor: 12.531

4.  Meta-analysis of the association of MTHFR polymorphisms with multiple myeloma risk.

Authors:  Li-Min Ma; Lin-Hai Ruan; Hai-Ping Yang
Journal:  Sci Rep       Date:  2015-05-29       Impact factor: 4.379

5.  A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: results from the IMMEnSE consortium and meta-analysis.

Authors:  Rafael Ríos-Tamayo; Carmen Belén Lupiañez; Daniele Campa; Thomas Hielscher; Niels Weinhold; Joaquin Martínez-López; Andrés Jerez; Stefano Landi; Krzysztof Jamroziak; Charles Dumontet; Marzena Wątek; Fabienne Lesueur; Rui Manuel Reis; Herlander Marques; Artur Jurczyszyn; Ulla Vogel; Gabriele Buda; Ramón García-Sanz; Enrico Orciuolo; Mario Petrini; Annette J Vangsted; Federica Gemignani; Asta Försti; Hartmut Goldschmidt; Kari Hemminki; Federico Canzian; Manuel Jurado; Juan Sainz
Journal:  Oncotarget       Date:  2016-09-13

Review 6.  Germline Risk Contribution to Genomic Instability in Multiple Myeloma.

Authors:  Siegfried Janz; Fenghuang Zhan; Fumou Sun; Yan Cheng; Michael Pisano; Ye Yang; Hartmut Goldschmidt; Parameswaran Hari
Journal:  Front Genet       Date:  2019-05-08       Impact factor: 4.599

7.  Genetically determined telomere length and multiple myeloma risk and outcome.

Authors:  Federico Canzian; Daniele Campa; Matteo Giaccherini; Angelica Macauda; Enrico Orciuolo; Marcin Rymko; Karolina Gruenpeter; Charles Dumontet; Malgorzata Raźny; Victor Moreno; Gabriele Buda; Katia Beider; Judit Varkonyi; Hervé Avet-Loiseau; Joaquín Martinez-Lopez; Herlander Marques; Marzena Watek; Maria Eugenia Sarasquete; Vibeke Andersen; Lionel Karlin; Anna Suska; Marcin Kruszewski; Niels Abildgaard; Marek Dudziński; Aleksandra Butrym; Arnold Nagler; Annette Juul Vangsted; Katalin Kadar; Tomczak Waldemar; Krzysztof Jamroziak; Svend Erik Hove Jacobsen; Lene Hyldahl Ebbesen; Michał Taszner; Grzegorz Mazur; Fabienne Lesueur; Matteo Pelosini; Ramon Garcia-Sanz; Artur Jurczyszyn; Delphine Demangel; Rui Manuel Reis; Elżbieta Iskierka-Jażdżewska; Miroslaw Markiewicz; Federica Gemignani; Edyta Subocz; Daria Zawirska; Agnieszka Druzd-Sitek; Anna Stępień; M Henar Alonso; Juan Sainz
Journal:  Blood Cancer J       Date:  2021-04-14       Impact factor: 11.037

Review 8.  Genome Instability in Multiple Myeloma: Facts and Factors.

Authors:  Anna Y Aksenova; Anna S Zhuk; Artem G Lada; Irina V Zotova; Elena I Stepchenkova; Ivan I Kostroma; Sergey V Gritsaev; Youri I Pavlov
Journal:  Cancers (Basel)       Date:  2021-11-26       Impact factor: 6.639
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.